Mode
Text Size
Log in / Sign up

Neonatal Sepsis

Part of Systemic Inflammatory Response Syndrome

Subtypes of Neonatal Sepsis

Early-onset sepsis (EOS) 1 Neonatal mortality/sepsis 1 Uncomplicated neonatal sepsis 1

9 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Neonatal Sepsis

7 trials tracked for Neonatal Sepsis: 3 in phase 3 or 4 and 2 with published results. The most-cited published study has 11 citations.

7Trials tracked
3Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 1 Phase 3 2 Phase 1 1 Other / NA 3
  1. Phase 3 Azithromycin-Prevention in Labor Use Study (A-PLUS) Completed · 11 cited
  2. Phase 4 Effect of Vitamin D as Adjuvant Therapy in Preterm Infants With Neonatal Sepsis Completed
  3. Phase 3 Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of Age Completed
  4. Phase 1 A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo) Completed
  5. N/A Smart Discharges for Mom & Baby Completed
  6. N/A Safety of Skin Cleansing With Chlorhexidine in Preterm Low Birth Weight Infants Completed
Show 1 more trials
  1. N/A Optimising Newborn Nutrition During Therapeutic Hypothermia. Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Systemic Inflammatory Response Syndrome

Related studies from across the Systemic Inflammatory Response Syndrome family.

Cystatin C shows good diagnostic performance with an AUC of 0.88 for early detection of SA-AKI
Nephrology Meta-analysis
Cystatin C shows good diagnostic performance with an AUC of 0.88 for early detection of SA-AKI Cystatin C shows promise for early detection of kidney injury
This meta-analysis of 17 studies evaluates the diagnostic performance of Cystatin C for detecting acute kidney injury in patients with sepsi…
A new look at 17 studies suggests that Cystatin C could help doctors identify kidney damage in sepsis patients much earlier than current met…
Sepsis Mortality Prediction Models Show Moderate Performance
Rheumatology Meta-analysis
Sepsis Mortality Prediction Models Show Moderate Performance Prediction models show moderate success in forecasting sepsis deaths
A meta-analysis of 84 studies finds that externally validated models for sepsis mortality achieve a pooled AUC of 0.794, but most studies ha…
New data from millions of records helps identify which factors most accurately predict if a patient with sepsis will survive.
Prediction models show moderate discrimination for ARDS occurrence and mortality in sepsis patients
Rheumatology Meta-analysis
Prediction models show moderate discrimination for ARDS occurrence and mortality in sepsis patients Machine Learning Models Show Mixed Results for Predicting Sepsis Lung Injury
This systematic review and meta-analysis evaluated prediction models for ARDS occurrence and short-term mortality in patients with sepsis-as…
New analysis shows that while machine learning can predict lung injury in sepsis patients, these models do not consistently outperform stand…
Gut microbiota dysbiosis and microbial metabolites impair renal function in sepsis-associated acute kidney injury
Nephrology Sys. Review
Gut microbiota dysbiosis and microbial metabolites impair renal function in sepsis-associated acute kidney injury Sepsis may damage kidneys by letting gut bacteria toxins leak into the blood
This narrative review examines the role of gut microbiota dysbiosis in sepsis-associated acute kidney injury and acute kidney injury. The au…
A review suggests that sepsis changes gut bacteria, causing harmful toxins to leak and hurt kidneys in humans and animals.
Modulation of neutrophil function and death in critically ill patients with sepsis is discussed in this narrative review
Allergy & Immunology Sys. Review
Modulation of neutrophil function and death in critically ill patients with sepsis is discussed in this narrative review Review discusses neutrophil modulation in sepsis for critically ill patients
This narrative review discusses modulation of neutrophil function and death in critically ill patients with sepsis. The authors synthesize c…
This narrative review explores how changing neutrophil function might affect sepsis outcomes in critically ill patients, though no specific …
Source control and antibiotic stewardship remain cornerstones of sepsis management
Infectious Disease Sys. Review
Source control and antibiotic stewardship remain cornerstones of sepsis management Review prioritizes antibiotic stewardship over live probiotics for sepsis
This narrative review synthesizes current evidence on sepsis management, emphasizing source control and antibiotic stewardship as key pillar…
A narrative review suggests avoiding live probiotics in high-risk sepsis patients while prioritizing antibiotic stewardship and source contr…
Antibiotic stewardship bundle aims to cut antibiotic use in Chinese NICUs
Infectious Disease Guideline
Antibiotic stewardship bundle aims to cut antibiotic use in Chinese NICUs A new plan aims to cut unnecessary antibiotics for sick newborns in China
This protocol describes a multicenter, before-and-after, interrupted time series quality improvement study testing a bundled antimicrobial s…
This ongoing project in China seeks to reduce antibiotic use for newborns with sepsis while keeping them safe during treatment.
Interleukin-7 therapy improves lymphocyte counts in sepsis and COVID-19 patients
Emergency Medicine Meta-analysis
Interleukin-7 therapy improves lymphocyte counts in sepsis and COVID-19 patients Recombinant human interleukin-7 boosts white blood cells but does not save lives in sepsis or COVID-19
A meta-analysis shows recombinant IL-7 boosts lymphocytes in sepsis and COVID-19, but only reduces secondary infections in COVID-19.
A new analysis shows this drug raises low white blood cell counts in sepsis and COVID-19 but does not lower death risk or improve survival.
Antioxidant nanomedicine in sepsis: a narrative review with no reported outcomes or safety data
Diabetes & Endocrinology Sys. Review
Antioxidant nanomedicine in sepsis: a narrative review with no reported outcomes or safety data Antioxidant nanomedicine review explores sepsis treatment options
This narrative review discusses antioxidant nanomedicine for sepsis. The authors note that key details such as population, sample size, outc…
A review looks at antioxidant nanomedicine for sepsis, a serious infection that kills many people. More research is needed to see if this ap…
Systematic review and meta-analysis of sepsis screening tools in low- and middle-income countries
Primary Care & Family Medicine Meta-analysis
Systematic review and meta-analysis of sepsis screening tools in low- and middle-income countries Sepsis screening tools show mixed accuracy in low-income country adult patient groups
This systematic review and meta-analysis evaluated sepsis screening tools in adult populations in low- and middle-income countries. It found…
A review of thirty thousand patients found that common sepsis checklists work differently in low-income areas. Some tools miss cases while o…
Narrative review on PAD4-mediated citrullination and PAD4-directed therapies for multiple inflammatory conditions
Drug Pipeline Sys. Review
Narrative review on PAD4-mediated citrullination and PAD4-directed therapies for multiple inflammatory conditions A new enzyme target could treat many serious diseases at once
This narrative review synthesizes evidence on PAD4-mediated citrullination and PAD4-directed therapies for conditions including rheumatoid a…
A single enzyme called PAD4 helps cause many different diseases, and new medicines targeting it might finally help people with multiple cond…
Secondary analysis of 342 sepsis patients reveals limited diagnostic utility for serum biomarkers in invasive candidiasis diagnosis
Emergency Medicine RCT
Secondary analysis of 342 sepsis patients reveals limited diagnostic utility for serum biomarkers in invasive candidiasis diagnosis Doctors tested blood markers to find infection signs in sick patients quickly
Analysis of 342 sepsis patients across German ICUs shows serum antigens rise in infection, but antibodies do not. Single biomarkers offer mo…
A study of 342 sick patients found that one specific blood test works best for spotting dangerous infections. Combining multiple tests did n…

Questions about Neonatal Sepsis

Does reducing antibiotic use help lower neonatal sepsis mortality rates?

Reducing unnecessary antibiotic use through antimicrobial stewardship strategies in newborns can lower both antibiotic exposure and mortality rates, especially in low-resource settings.

Full answer →
Does maternal preeclampsia increase the risk of neonatal sepsis in my baby?

Yes, maternal preeclampsia is linked to a modestly higher risk of neonatal sepsis in the first 28 days of life, based on a large meta-analysis.

Full answer →